# Project State

## Project Reference

See: .planning/PROJECT.md (updated 2026-03-28)

**Core value:** Klinik olarak makul, veri sizintisina dayanikli ve yeniden uretilebilir bir offline RL benchmark'i olusturmak.
**Current focus:** Planning documentation is reconciled with the completed implementation; next work is packaging/commit hygiene and any final project-proposal deliverables.

## Current Position

Phase: 9 of 9 (Evaluation, Safety, and Reproducible Package)
Plan: 17 of 17 completed
Status: All roadmap phases complete; `.planning` docs were backfilled/reconciled on 2026-05-22
Last activity: 2026-05-22 - Backfilled missing plan summaries for Phases 1, 2, and 5; updated ROADMAP/STATE to match the implemented repo

Progress: [██████████] 100% (9 of 9 phases complete)

## Performance Metrics

**Velocity:**
- Total plans completed: 17
- Completed phases: 9/9
- Planning docs now present for every roadmap plan

**By Phase:**

| Phase | Plans | Total | Status |
|-------|-------|-------|--------|
| 1 | 2 | 2 | ✅ Complete |
| 2 | 2 | 2 | ✅ Complete |
| 3 | 1 | 1 | ✅ Complete |
| 4 | 2 | 2 | ✅ Complete |
| 5 | 2 | 2 | ✅ Complete |
| 6 | 2 | 2 | ✅ Complete |
| 7 | 2 | 2 | ✅ Complete |
| 8 | 2 | 2 | ✅ Complete |
| 9 | 2 | 2 | ✅ Complete |

**Recent Trend:**
- Last planning-doc reconciliation: 01-01, 01-02, 02-01, 02-02, 05-01, 05-02 summaries created/backfilled
- Trend: Complete / documentation reconciliation

## Accumulated Context

### Decisions

Decisions are logged in PROJECT.md Key Decisions table. Recent decisions affecting the completed project:

- Phase 1 locks the adult ICU Sepsis-3 cohort before onset logic or MDP construction.
- Phase 2 assigns one selected onset or explicit unusable status, then materializes deterministic 4-hour episode windows.
- Phase 3 owns patient-level split manifests so all later scalers, bins, and transforms stay train-only.
- Phase 4 defines the state feature contract and train-only preprocessing path.
- Phase 5 uses a discrete 25-action vasopressor-by-IV-fluid grid and a versioned reward contract.
- The main training path stays device-agnostic so the same code runs on Apple Silicon `MPS`, NVIDIA `CUDA`, or CPU fallback.
- Custom PyTorch trainers are used instead of JAX; PyTorch remains the implementation framework for CQL, BCQ, and IQL.
- CQL is the reference algorithm; BCQ and IQL reuse `common.py`, `device.py`, and `TrainingConfig` without forking the runtime surface.
- BCQ and IQL emit the same checkpoint-manifest and JSONL curve envelope as CQL, so comparison tooling stays algorithm-agnostic.
- Evaluation claims remain retrospective research claims; OPE is not evidence of bedside efficacy.
- Comparison and reporting artifacts should flag dataset-contract drift instead of silently merging incompatible runs.

### Phase Completion Summary

**Phase 1 — Cohort Definition ✅**
- `src/mimic_sepsis_rl/data/cohort/spec.py`, `extract.py`, `audit.py`, `models.py`
- `src/mimic_sepsis_rl/cli/build_cohort.py`
- `configs/cohort/default.yaml`
- `docs/cohort_selection.md`
- Summaries: `01-01-SUMMARY.md`, `01-02-SUMMARY.md`

**Phase 2 — Onset Anchoring and Episode Grid ✅**
- `src/mimic_sepsis_rl/data/onset.py`, `onset_models.py`, `episodes.py`, `episode_models.py`
- `src/mimic_sepsis_rl/cli/build_episode_grid.py`
- `configs/onset/default.yaml`
- Summaries: `02-01-SUMMARY.md`, `02-02-SUMMARY.md`

**Phase 3 — Split Manifests and Leakage Boundaries ✅**
- `src/mimic_sepsis_rl/data/splits.py`
- `configs/splits/default.yaml`
- `docs/leakage_boundaries.md`
- Summary: `03-01-SUMMARY.md`

**Phase 4 — State Representation Pipeline ✅**
- `src/mimic_sepsis_rl/mdp/features/dictionary.py`, `extractors.py`
- `configs/features/default.yaml`
- `docs/feature_dictionary.md`
- Summaries: `04-01-SUMMARY.md`, `04-02-SUMMARY.md`

**Phase 5 — Treatment and Reward Encoding ✅**
- `src/mimic_sepsis_rl/mdp/actions/vasopressors.py`, `fluids.py`, `bins.py`
- `src/mimic_sepsis_rl/mdp/rewards.py`, `reward_models.py`
- `docs/action_mapping.md`, `docs/reward_spec.md`
- Summaries: `05-01-SUMMARY.md`, `05-02-SUMMARY.md`

**Phase 6 — Transition Dataset and Baseline Benchmarks ✅**
- `src/mimic_sepsis_rl/datasets/transitions.py`, `replay_buffer.py`
- `src/mimic_sepsis_rl/cli/build_transitions.py`
- `src/mimic_sepsis_rl/baselines/*`
- `docs/baseline_benchmarks.md`
- Summaries: `06-01-SUMMARY.md`, `06-02-SUMMARY.md`

**Phase 7 — CQL Reference Training ✅**
- `src/mimic_sepsis_rl/training/device.py`, `config.py`, `common.py`, `cql.py`
- `configs/training/runtime.mps.yaml`, `runtime.cuda.yaml`, `cql.yaml`
- `docs/cql_training.md`, `docs/cql_run_report.md`, `docs/assets/cql-run/*`
- Summaries: `07-01-SUMMARY.md`, `07-02-SUMMARY.md`

**Phase 8 — Comparative Offline RL Experiments ✅**
- `src/mimic_sepsis_rl/training/registry.py`, `experiment_runner.py`, `bcq.py`, `iql.py`, `comparison.py`
- `configs/training/bcq.yaml`, `iql.yaml`
- `docs/model_comparison.md`
- Summaries: `08-01-SUMMARY.md`, `08-02-SUMMARY.md`

**Phase 9 — Evaluation, Safety, and Reproducible Package ✅**
- `src/mimic_sepsis_rl/evaluation/ope.py`, `safety.py`, `ablations.py`
- `src/mimic_sepsis_rl/reporting/package.py`, `offline_rl.py`
- `docs/evaluation_protocol.md`, `docs/reproducibility.md`
- Summaries: `09-01-SUMMARY.md`, `09-02-SUMMARY.md`

### Current Workspace Notes

- `.gitignore` currently has local additions for `graphify-out` and `commit_history`.
- `proje_onerisi_iql/` currently contains a Turkish IQL project proposal source/PDF plus LaTeX build artifacts.
- `.planning/` now has a summary file for every plan listed in `ROADMAP.md`.

### Pending Todos

- Decide whether `proje_onerisi_iql/proje_onerisi.tex` and `proje_onerisi_iql/proje_onerisi.pdf` should be committed, and whether LaTeX auxiliary files should be ignored or removed.
- Stage/commit the `.planning` reconciliation and `.gitignore` hygiene changes when ready.
- If Graphify is part of the final workflow, rerun `graphify update .` and `graphify export obsidian` after committing or before final packaging.

### Blockers/Concerns

- Large/local generated directories should stay out of git (`graphify-out`, `commit_history`, LaTeX aux files if not needed).
- Retrospective OPE/safety outputs remain research evidence only; they must not be described as prospective bedside efficacy.
- Full clinical validity still depends on the real MIMIC-IV data extraction and externally reviewed cohort/onset assumptions.

## Session Continuity

Last session: 2026-05-22 13:20 +03
Stopped at: Planning docs reconciled with completed roadmap; verification command passed for backfilled Phase 1/2/5 summaries
Resume file: None
